269 related articles for article (PubMed ID: 24629496)
21. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
Clonfero E; Jongeneelen F; Zordan M; Levis AG
IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
[TBL] [Abstract][Full Text] [Related]
22. Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar.
Gabbani G; Pavanello S; Nardini B; Tognato O; Bordin A; Fornasa CV; Bezze G; Clonfero E
Mutat Res; 1999 Mar; 440(1):27-33. PubMed ID: 10095126
[TBL] [Abstract][Full Text] [Related]
23. Cancer risk from incidental ingestion exposures to PAHs associated with coal-tar-sealed pavement.
Williams ES; Mahler BJ; Van Metre PC
Environ Sci Technol; 2013 Jan; 47(2):1101-9. PubMed ID: 23181746
[TBL] [Abstract][Full Text] [Related]
24. Formation of DNA adducts in the skin of psoriasis patients, in human skin in organ culture, and in mouse skin and lung following topical application of coal-tar and juniper tar.
Schoket B; Horkay I; Kósa A; Páldeák L; Hewer A; Grover PL; Phillips DH
J Invest Dermatol; 1990 Feb; 94(2):241-6. PubMed ID: 2299199
[TBL] [Abstract][Full Text] [Related]
25. Human skin aryl hydrocarbon hydroxylase. Induction by coal tar.
Bickers DR; Kappas A
J Clin Invest; 1978 Nov; 62(5):1061-8. PubMed ID: 711851
[TBL] [Abstract][Full Text] [Related]
26. Uptake of pyrene in a breast-fed child of a mother treated with coal tar.
Scheepers PT; van Houtum JL; Anzion RB; Harder R; Bos RP; van der Valk PG
Pediatr Dermatol; 2009; 26(2):184-7. PubMed ID: 19419468
[TBL] [Abstract][Full Text] [Related]
27. Estimation of risk of developing bladder cancer among workers exposed to coal tar pitch volatiles in the primary aluminum industry.
Tremblay C; Armstrong B; Thériault G; Brodeur J
Am J Ind Med; 1995 Mar; 27(3):335-48. PubMed ID: 7747740
[TBL] [Abstract][Full Text] [Related]
28. Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation.
Borska L; Smejkalova J; Cerna M; Hamakova K; Kucera I; Kremlacek J; Pelikanova D; Fiala Z
Mutat Res; 2010 Feb; 696(2):144-7. PubMed ID: 20096371
[TBL] [Abstract][Full Text] [Related]
29. [Mutagenic effects of coal tar used in the treatment of psoriasis].
Gardosová D; Mezencevová V; Kalina I; Hejj F; Kopka M; Petrovicová J
Bratisl Lek Listy; 1997 Mar; 98(3):146-9. PubMed ID: 9264819
[TBL] [Abstract][Full Text] [Related]
30. Genotoxic effect of Goeckerman regimen of psoriasis.
Fiala Z; Borska L; Pastorkova A; Kremlacek J; Cerna M; Smejkalova J; Hamakova K
Arch Dermatol Res; 2006 Oct; 298(5):243-51. PubMed ID: 16902768
[TBL] [Abstract][Full Text] [Related]
31. [Mutagenic activity of urine of patients with psoriasis treated with pharmaceutical black coal tar].
Gardosová D; Kalina I; Hejj F; Mezencevová V; Salagovic J; Némethová G
Cas Lek Cesk; 1994 Aug; 133(15):463-6. PubMed ID: 8082111
[TBL] [Abstract][Full Text] [Related]
32. Comment on "cancer risk from incidental ingestion exposures to PAHs associated with coal-tar-sealed pavement".
Magee B; Keating-Connolly J
Environ Sci Technol; 2014; 48(1):868-9. PubMed ID: 24328310
[No Abstract] [Full Text] [Related]
33. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
Thawornchaisit P; Harncharoen K
J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
[TBL] [Abstract][Full Text] [Related]
34. Response to comment on "cancer risk from incidental ingestion exposures to PAHs associated with coal-tar-sealed pavement".
Williams ES; Mahler BJ; Van Metre PC
Environ Sci Technol; 2014; 48(1):870-1. PubMed ID: 24328334
[No Abstract] [Full Text] [Related]
35. [Longitudinal study of the excretion of 1-hydroxypyrene in urine after external treatment with coal tar].
Nenoff P; Richter B; Will W; Haustein UF
Hautarzt; 1997 Apr; 48(4):240-5. PubMed ID: 9206711
[TBL] [Abstract][Full Text] [Related]
36. Holistic development of coal tar lotion by embedding design of experiments (DoE) technique: preclinical investigations.
Sharma M; Sharma G; Singh B; Dhiman V; Bhadada SK; Katare OP
Expert Opin Drug Deliv; 2020 Feb; 17(2):255-273. PubMed ID: 31990219
[No Abstract] [Full Text] [Related]
37. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005.
Bosetti C; Boffetta P; La Vecchia C
Ann Oncol; 2007 Mar; 18(3):431-46. PubMed ID: 16936186
[TBL] [Abstract][Full Text] [Related]
38. A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis.
Smith CH; Jackson K; Chinn S; Angus K; Barker JN
Clin Exp Dermatol; 2000 Nov; 25(8):580-3. PubMed ID: 11167965
[TBL] [Abstract][Full Text] [Related]
39. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis.
Pinheiro N
Br J Clin Pract; 1997; 51(1):16-9. PubMed ID: 9158266
[TBL] [Abstract][Full Text] [Related]
40. [Coal tar dissolved in chloroform in dermatological therapy. Clinical trials].
Tobia L
Minerva Med; 1971 Mar; 62(22):1188-9. PubMed ID: 5551951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
